OVERDOSAGE AND-OR POISONING INFORMATION GAP

被引:1
作者
BOLGER, PB
SHIMOMURA, SK
CUPIT, GC
DAVIS, LJ
MCCART, GM
机构
[1] UNIV CALIF SAN FRANCISCO,SCH PHARM,DIV CLIN PHARM,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN DIEGO,HOSP PHARM,SAN DIEGO,CA 92103
[3] UNIV CALIF SAN DIEGO,PHARM CLIN,SAN DIEGO,CA 92103
关键词
D O I
10.1002/j.1552-4604.1979.tb02474.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The availability of poisoning information from the pharmaceutical industry was evaluated. Manufacturers of the top 50 drugs were surveyed. Information that was received was classified by established criteria for evaluation. Compendia on poisoning information was evaluated based on 11 components ranging from toxicity information to information available in the PDR. Additional information on emergency telephone numbers for after-hours service was accumulated. The results showed that much of the information available is incomplete and/or outdated. A concerted effort to establish a central source for manufacturers' poison information needs to be begun.
引用
收藏
页码:160 / 164
页数:5
相关论文
共 7 条
[1]  
Comstock E G, 1975, Drug Inf J, V9, P81
[2]   OVERDOSAGE AND/OR POISONING - INFORMATION GAP [J].
ELLENHORN, MJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 13 (5-6) :181-189
[3]  
JENNINGS J, 1967, FDA PAP, V1, P10
[4]  
ORTIZ EM, 1971, FDA PAP, V5, P7
[5]  
1976, PHARMACY TIMES APR, P40
[6]  
1974, CHAIN STORE AGE DRUG, V50, P33
[7]  
1970, FED REG 0206, V35, P2656